1. Home
  2. BGLC vs ROMA Comparison

BGLC vs ROMA Comparison

Compare BGLC & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • ROMA
  • Stock Information
  • Founded
  • BGLC N/A
  • ROMA 2018
  • Country
  • BGLC Malaysia
  • ROMA Hong Kong
  • Employees
  • BGLC 30
  • ROMA N/A
  • Industry
  • BGLC Medical Specialities
  • ROMA Savings Institutions
  • Sector
  • BGLC Health Care
  • ROMA Finance
  • Exchange
  • BGLC Nasdaq
  • ROMA Nasdaq
  • Market Cap
  • BGLC 9.1M
  • ROMA 8.1M
  • IPO Year
  • BGLC N/A
  • ROMA 2024
  • Fundamental
  • Price
  • BGLC $0.52
  • ROMA $0.54
  • Analyst Decision
  • BGLC
  • ROMA
  • Analyst Count
  • BGLC 0
  • ROMA 0
  • Target Price
  • BGLC N/A
  • ROMA N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • ROMA 178.9K
  • Earning Date
  • BGLC N/A
  • ROMA 08-23-2024
  • Dividend Yield
  • BGLC N/A
  • ROMA N/A
  • EPS Growth
  • BGLC N/A
  • ROMA N/A
  • EPS
  • BGLC N/A
  • ROMA N/A
  • Revenue
  • BGLC N/A
  • ROMA $1,745,726.00
  • Revenue This Year
  • BGLC N/A
  • ROMA N/A
  • Revenue Next Year
  • BGLC N/A
  • ROMA N/A
  • P/E Ratio
  • BGLC N/A
  • ROMA N/A
  • Revenue Growth
  • BGLC N/A
  • ROMA N/A
  • 52 Week Low
  • BGLC N/A
  • ROMA $0.40
  • 52 Week High
  • BGLC N/A
  • ROMA $11.80
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 54.78
  • ROMA N/A
  • Support Level
  • BGLC $0.46
  • ROMA N/A
  • Resistance Level
  • BGLC $0.59
  • ROMA N/A
  • Average True Range (ATR)
  • BGLC 0.04
  • ROMA 0.00
  • MACD
  • BGLC 0.01
  • ROMA 0.00
  • Stochastic Oscillator
  • BGLC 45.41
  • ROMA 0.00

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for our clients' organizations and the world.

Share on Social Networks: